AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond
396 View
- Publish Date:
- 6 June, 2022
- Category:
- CNBC
- Video License
- Standard License
- Imported From:
- Youtube
Christopher Raymond, Piper Sander senior biotech analyst, joins 'Power Lunch' to discuss what it means for biotech companies to be defensive, Raymond's thoughts around Abbvie and if biotech companies have hit a bottom.
Houston News
![]()
By: CNBC Television
Title: AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond
Sourced From: www.youtube.com/watch?v=SqzB2lTMjbw
News.... browse around here
Trading News: https://branch.centuryac.com/qcnfl/celebrities-who-disc-golf.html
Exciting Finds: Zet news roundup
Stay up to date on China: https://www.chinapulse.com/data-news/2021/05/21/jd-logistics-raises-3-16-billion-in-hong-kong-ipos-reuters/
Florida rehab centers key to reducing overdose deaths
https://www.utehoki.hu/lib/magpierss-0.72//scripts/magpie_slashbox.php?rss_url=https://www.maxsynapseinfo.com/rss_Jt2Xn.xmlHouston News
